Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference

3 years ago

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience…

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer

3 years ago

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully…

Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow

3 years ago

WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a…

Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

3 years ago

WALTHAM, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…

Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission

3 years ago

A preclinical study in hamsters showed both a decrease in infectious virus and in transmission Phase 1 data measuring cross-reactivity also…

Tricida Announces Administrative Stop of the VALOR-CKD Trial

3 years ago

Expects to Announce Top-Line Results Early in the Fourth Quarter of 2022SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE)…

TOMI CEO Dr. Halden Shane to Present at the H.C. Wainwright Global Investment Conference

3 years ago

FREDERICK, Md., May 19, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection…

WIMI Hologram Academy: Virtual Reality Technology Provides An Immersive Recovery Experience

3 years ago

HONG KONG, May 19, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

3 years ago

Cells Derived from Healthy, Younger Donors were More Abundant with Greater Fitness and Cancer Killing Potential Than Cells Derived from…

Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference

3 years ago

Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an…